Author

Alekshyander Mishra

Duke University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:scRNA-seq· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

Rohan BhattacharyaiD· 2 shared Samira MusahiD· 2 shared Sophia M. LeemaniD· 2 shared Titilola D. KalejaiyeiD· 2 shared Christine E. SeidmaniD· 1 shared Christopher John SperatiiD· 1 shared Daniel Silas· 1 shared Gentzon HalliD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Rohan BhattacharyaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Engineered human iPS cell models reveal altered podocytogenesis and glomerular capillary wall in CHD-associated SMAD2 mutations

Rohan Bhattacharya, Tarsha L. Ward, Titilola D. Kalejaiye, Alekshyander Mishra, Sophia M. Leeman, Hamidreza Arzaghi, Jonathan G. Seidman, Christine E. Seidman, Samira Musah

This study uses engineered human iPSCs to show that SMAD2 mutations linked to CHD disrupt kidney podocytogenesis and glomerular structure, leading to proteinuria.

Nature Biomedical Engineering · Nov 3, 2025Peer-reviewedBioengineering

A Novel TRPC6 Mutation Causes Autosomal Dominant FSGS

Rohan Bhattacharya, Xingrui Mou, Sophia M. Leeman, Alekshyander Mishra, Titilola D. Kalejaiye, Megan Stangl, Daniel Silas, Karen L. Soldano, Christopher John Sperati, Opeyemi A. Olabisi, Gentzon Hall, Samira Musah

The paper reports a novel TRPC6 mutation causing autosomal dominant FSGS and shows that combined Sildenafil and Losartan therapy improves podocyte dysfunction.

bioRxiv · Feb 11, 2025 · PreprintGenetics